Rite Aid (RAD) Downgraded by Vetr to Buy
Rite Aid (NYSE:RAD) was downgraded by analysts at Vetr from a “strong-buy” rating to a “buy” rating in a research note issued on Thursday. They currently have a $2.47 price objective on the stock. Vetr‘s price objective points to a potential upside of 3.35% from the stock’s previous close.
A number of other equities research analysts also recently issued reports on the stock. Zacks Investment Research downgraded shares of Rite Aid from a “hold” rating to a “sell” rating in a report on Tuesday, January 9th. Evercore ISI assumed coverage on shares of Rite Aid in a report on Thursday, January 4th. They issued an “underperform” rating and a $1.50 target price for the company. Deutsche Bank assumed coverage on shares of Rite Aid in a report on Monday, December 4th. They issued a “hold” rating and a $2.25 target price for the company. Royal Bank of Canada set a $2.00 price objective on shares of Rite Aid and gave the stock a “hold” rating in a research note on Wednesday, October 25th. Finally, Mizuho set a $2.00 price objective on shares of Rite Aid and gave the stock a “hold” rating in a research note on Saturday, October 7th. Three research analysts have rated the stock with a sell rating, five have issued a hold rating and three have given a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus price target of $2.74.
Rite Aid (NYSE:RAD) traded up $0.05 during trading hours on Thursday, hitting $2.39. 58,084,245 shares of the stock were exchanged, compared to its average volume of 27,490,000. Rite Aid has a twelve month low of $1.38 and a twelve month high of $8.77. The firm has a market capitalization of $2,540.00, a price-to-earnings ratio of 21.73 and a beta of 1.83. The company has a current ratio of 0.86, a quick ratio of 0.59 and a debt-to-equity ratio of 3.66.
Rite Aid Company Profile
Rite Aid Corporation is a retail drugstore chain. The Company’s segments include Retail Pharmacy and Pharmacy Services. The Company operates under The Rite Aid name. It operates approximately 4,560 stores in over 30 states across the country and in the District of Columbia. The Company’s Retail Pharmacy segment consists of Rite Aid stores, RediClinic and Health Dialog.
To view Vetr’s full report, visit Vetr’s official website.
Receive News & Ratings for Rite Aid Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rite Aid and related companies with MarketBeat.com's FREE daily email newsletter.